Skip to main content

Advertisement

Table 1 Cancer cohort: characteristics and number of mtDNA mutations identified

From: Performance of mitochondrial DNA mutations detecting early stage cancer

Sample Age Diagnosis Stage Blood/Tumor Blood/Body Fluid*
Lung 1 54 SCC IA 6 1
Lung 2 51 Adenocarcinoma IA 3 n/a
Lung 3 72 Adenocarcinoma IA 2 (D-Loop) 0
Lung 4 70 BALV CA IA 2 0
Lung 5 77 SCC IA 3 0
Lung 6 61 Adenocarcinoma IIA 0 1
Lung 7 73 NSCLC IIB 0 0
Lung 9 64 Carcinoid Tumor IA 1 1
Bladder 1 86 TCC I 1 n/a
Bladder 2 53 SCC I 1 0
Bladder 3 62 Large Cell Undifferentiated CA I 1 0
Bladder 4 72 TCC II n/a 4
Kidney 1 74 Renal Cell CA II 3 0
Kidney 2 58 Renal Cell CA II/IV 2 n/a
Kidney 3 65 Renal Cell CA III 1 0
Kidney 4 72 Renal Cell CA III 2 0
Kidney 5 66 Renal Cell CA II 1 n/a
Kidney 6 52 Renal Cell CA II/III 2 1
Kidney 7 33 Renal Cell CA I n/a 0
Kidney 8 61 Renal Cell CA II 0 1
Kidney 9 75 Renal Cell CA II 1 0
Kidney 10 62 Renal Cell CA I 0 1
Kidney 11 21 Renal Cell CA II 0 0
Kidney 12 44 Renal Cell CA I 0 1
Kidney 13 59 Renal Cell CA II 1 0
Kidney 14 59 Renal Cell CA I 1 (D-Loop) 0
  1. * all lung body fluids were pre-amplified by WGA